# Commission Regulation (EU) No 1048/2012 of 8 November 2012 on the authorisation of a health claim made on foods and referring to the reduction of disease risk (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

Permitted health claim
Application — Relevant provisions of Regulation (EC) No 1924/2006
Applicant — Address
Nutrient, substance, food or food category
Claim
Conditions of use of the claim
Conditions and/or restrictions of use of the food and/or additional statement or warning
EFSA opinion reference
Article 14(1)(a) health claim referring to a reduction of a disease risk
Cargill Incorporated, acting through Cargill Health and Nutrition, c/o Cargill R & D Centre Europe, Havenstraat 84, 1800 Vilvoorde, Belgium
Barley beta-glucan
Barley beta-glucan has been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease.
Information shall be given to the consumer that the beneficial effect is obtained with a daily intake of 3 g of barley beta-glucan.
The claim can be used for foods which provide at least 1 g of barley beta-glucan per quantified portion.
Q-2011-00798
Valens Int. d.o.o., Kidričeva ulica 24b, SI-3000 Celje, Slovenia
Q-2011-00799

---
Source: https://www.legislation.gov.uk/eur/2012/1048/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2012-1048/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.